Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method

An automated cloud-based system for diagnostically field testing a sample taken from a subject using an automated portable handheld instrument to determine a presence of viral antigens and/or antibodies thereto comprising:

• a sample receiving chamber in a rotatable disc in the instrument;
• a reader for automatically processing the sample in the rotatable disc using the instrument according to a nature of the sample and a corresponding means of detection in the portable handheld instrument of the viral antigens and/or antibodies subject to diagnostic testing;
• a detector for automatically detecting a quantitative measure of the viral antigens and/or antibodies in the sample using the corresponding means of detection in the portable handheld instrument;
• a data output circuit for automatically generating the detected quantitative measure of the viral antigens and/or antibodies in the sample corresponding to the subject;
• a communication circuit for automatically communicating the data output corresponding to the subject to a cloud-based database;
• a cloud based ecosystem configured to comparatively analyze under automated control the communicated data output corresponding to the subject relative to a plurality of different types of viral antigens and/or antibodies to diagnose the type of viral infection, if any, the subject most likely carries or has previously carried, and for automatically communicating the results of the comparative analysis to the subject from the cloud based ecosystem,
• where the cloud based ecosystem configured to comparatively analyze under automated control the communicated data output corresponding to the subject relative to a plurality of different types of viral antigens and/or antibodies to diagnose type of viral infection, if any, the subject most likely carries or has previously carried comprises a cloud-based module configured to automatically analyze the communicated data output of the microarray for positive and/or negative indications of Covid-19 antigens and/or antibodies, to automatically compare the communicated data output for positive and/or negative indications of Covid-19 to communicated data output for positive and/or negative indications of a microarray for a plurality of viral infections sharing at least some of the Covid-19 antigens and/or antibodies, and to automatically determine whether the communicated data output of positive and/or negative indications of Covid-19 are statistically indicative of Covid-19 rather than the plurality of viral infections sharing at least some of the Covid-19 antigens and/or antibodies, so that false positives and/or false negatives are substantially reduced.